Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2002
06/12/2002EP1212075A1 Peptides capable of modulating the function of cd66 (ceacam) family members
06/12/2002EP1212074A1 Hybrid peptides modulate the immune response
06/12/2002EP1212066A1 Pro-gut maturation and anti-inflammatory effects of lactobacillus and lactobacillus secreted proteins, carbohydrates and lipids
06/12/2002EP1211933A1 Pa28 modified transgenic mice
06/12/2002EP1211931A1 A knockout mouse for the tumor suppressor gene anx7
06/12/2002EP1084227A4 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
06/12/2002EP1056474B1 Affinity markers for human serum albumin
06/12/2002EP1039922B1 Improved interferon polymer conjugates
06/12/2002EP0822941B1 Monoclonal antibodies against hiv-1 and vaccines made thereof
06/12/2002EP0802800B1 Biocompatible immunoisolatory capsules containing genetically altered cells for the delivery of biologically active molecules
06/12/2002EP0777677B1 Methods of identifying compounds useful for treating autoimmune diseases
06/12/2002EP0759774B1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic
06/12/2002EP0749325B1 Bispecific molecules having clinical utilities
06/12/2002EP0749317B1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
06/12/2002EP0741576B1 Co-administration of interleukin-3 mutants with colony stimulating factors
06/12/2002EP0734391B1 Pna-dna-pna chimeric macromolecules
06/12/2002EP0722452B1 Nf-at polypeptides and polynucleotides
06/12/2002EP0669833B1 Type ii tgf-beta-binding receptor fragment as therapeutic agent
06/12/2002EP0574395B1 Cytokine immunoconjugates
06/12/2002EP0433372B1 Oral immunization by transgenic plants
06/12/2002CN1353764A Method for selecting improved vectors
06/12/2002CN1353762A Pectate lyase fusion for expression and secretion of polypeptides
06/12/2002CN1353761A Preparation of biologically active molecules
06/12/2002CN1353756A Compositions and method for the modification of gene expression
06/12/2002CN1353755A Method of removing N-terminal alanine residues from polypeptides with aeromonas aminopeptidase
06/12/2002CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway
06/12/2002CN1353753A Oligouncleotide for detection and identification of mycobacteria
06/12/2002CN1353678A Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
06/12/2002CN1353614A Method of treating chronic cardiac disease
06/12/2002CN1353187A Vegetable lectin gene
06/12/2002CN1353115A Synthesis and expression of recombinant human parathyroxin gene
06/12/2002CN1353114A Human papillomavirus 11L1-E7 recombination protein and its application
06/11/2002USRE37741 Purified nontypable Haemophilus influenzae P5 protein as a vaccine for nontypable Haemophilus influenzae infection
06/11/2002US6404779 System and method of disharmonic frequency multiplexing
06/11/2002US6403957 Nucleic acid reading and analysis system
06/11/2002US6403865 Fertile transgenic maize plant comprising foreign dna sequence encoding bacillus thuringiensis insecticidal protein toxic to european corn borer stably incorporated into genome which expresses protein in leaf tissue causing mortality to borer
06/11/2002US6403864 Precursor polypeptide of a plant growth factor, a gene encoding a precursor polypeptide of a plant growth factor and a method for promotion of plant growth
06/11/2002US6403862 Isolated promoter capable of driving transcription in seed-preferred manner which comprises polynucleotide having specified sequence
06/11/2002US6403860 Ku80 homologue and uses thereof
06/11/2002US6403785 Isolated DNA molecule encoding human TSC403
06/11/2002US6403784 Human uncoupling proteins and polynucleotides encoding the same
06/11/2002US6403783 Isolated nucleic molecule encoding new polypeptide having diagnostic and therapeutic uses
06/11/2002US6403782 Nucleic acid encoding eotaxin
06/11/2002US6403780 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof
06/11/2002US6403771 Loading onto binding medium relatively long lived radioisotope, decay sequence yielding daughter isotopes that emit predominantly alpha-and/or beta-particles, eluting alpha-particle emitting isotope, coupling to targeting moiety
06/11/2002US6403770 Antibodies to neutrokine-alpha
06/11/2002US6403769 Fusion protein having nonantibody portion comprised of effector domain from growth factor or growth factor receptor joined to aminoterminal end of immunoglobulin g-derived sequence which lacks ch1 domain
06/11/2002US6403768 Manipulation of Mlo genes to enhance disease resistance in plants
06/11/2002US6403767 Polypeptide molecules of the G protein-coupled heptahelical receptor superfamily and uses therefor
06/11/2002US6403766 Isolated human actin-binding regulatory protein expressed in motile, proliferating and invasive cells and in cells at wound sites
06/11/2002US6403765 Truncated Apaf-1 and methods of use thereof
06/11/2002US6403764 Variant wherein amino acid residue at position 16 of native-sequence human igf-1 is replaced with glycine or serine, or amino acid residue at position 25 or 49 or residues at 3 and 49 are replaced with alanine, glycine, or serine
06/11/2002US6403763 Chiral peptide nucleic acids which hybridize strongly with complementary nucleic acids; antigene and antisense agents; tools in molecular biology
06/11/2002US6403559 C-kit ligand-based method for expanding peripheral blood cell levels
06/11/2002US6403558 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
06/11/2002US6403557 Fibroblast growth factor-13
06/11/2002US6403556 Pharmaceutical preparation containing protein C and a thrombolytically active substance
06/11/2002US6403553 Induced by chemotherapy, irradiation, or disease; macrophage inflammatory proteins give significant and specific increase of platelet count
06/11/2002US6403552 Ob receptor and methods for the diagnosis and treatment of body weight disorders
06/11/2002US6403374 Long wavelength engineered fluorescent proteins
06/11/2002US6403373 Isolated nucleic acid molecules associated with colon, renal, and stomach cancer and methods of using these
06/11/2002US6403372 Aspergillus fumigatus profilin
06/11/2002US6403370 Generation an infection, reproduction, genetic engineering
06/11/2002US6403361 Enzymatic method for modification of recombinant polypeptides
06/11/2002US6403360 Isolated nucleic acids
06/11/2002US6403337 Staphylococcus aureus genes and polypeptides
06/11/2002US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering
06/11/2002US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering
06/11/2002US6403334 gidB from Staphylococcus aureus
06/11/2002US6403325 Methods and compounds for treating alzheimer's disease
06/11/2002US6403323 Ampa-binding human GluR3 receptors
06/11/2002US6403319 Mixing nucleic acid samples with hairpin primers; incubation, amplification, hybridization, and detection; sequence determination, genetic engineering
06/11/2002US6403318 Fatty acid synthase mRNA binding protein
06/11/2002US6403308 Methods for detecting and reversing resistance to macrocyclic lactone compounds
06/11/2002US6403307 Amplification of genomic dna or mrna or complement; analyzing for mutation
06/11/2002US6403306 Detection and diagnosis of meningococcal strains; vaccines with capsular polysaccharide conjugates; genetic engineering
06/11/2002US6403305 Genetic expression of self-activating fusion protein in cell; testing tethered combinatorial peptide libraries
06/11/2002US6403304 Human osteoclast-specific and -related DNA sequences
06/11/2002US6403299 Transforming non-leflunomide resistant cell with dna sequence encoding deah box protein that binds atp and nucleic acid; culturing; modulating helicase activity; genetic engineering
06/11/2002US6403103 Cytoplasmic protein fragment selected from: the amino acid sequence from residue 402 to residue 426 of seq id no: 2; and an immunogenic fragment of said amino acid sequence comprising at least residue 408 to residue 417 of said amino acid
06/11/2002US6403102 Chlamydia antigens and corresponding DNA fragments and uses thereof
06/11/2002US6403101 Chlamydia antigens and corresponding DNA fragments and uses thereof
06/11/2002US6403100 Method of attenuating pathogenic mycobacteria and strains of mycobacteria so attenuated
06/11/2002US6403099 Conjugates formed from heat shock proteins and oligo-or polysaccharides
06/11/2002US6403097 Deletion in the glycoprotein ge-gene
06/11/2002US6403096 Dimer, linked by a disulfide bridge; improves the uptake of therapeutic and diagnostic agents at a tumor site
06/11/2002US6403094 Clostridium perfringens vaccines
06/11/2002US6403093 Methods to detect granulocytic ehrlichiosis
06/11/2002US6403092 Immune response modulator alpha-2 macroglobulin complex
06/11/2002US6403091 Produced by the hybridoma having atcc accession no. hb 10916.
06/11/2002US6403090 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine
06/11/2002US6403088 Antibodies reactive with VEGF-C, a ligand for the Flt4 receptor tyrosine kinase (VEGFR-3)
06/11/2002US6403087 Soluble lymphotoxin-β receptors as therapeutic agents for the treatment of immunological disease
06/11/2002US6403082 Administering polynucleotide
06/11/2002US6403080 Methods of modulating an immune response to antigen, and cells for use in the method
06/11/2002US6403079 Using polypeptide
06/11/2002US6403077 Treatment regimes featuring an IL-10-containing chimeric polypeptide
06/11/2002US6403076 Polypeptides
06/11/2002US6402913 Separation of plasma components
06/11/2002CA2276614C Analogs of parathyroid hormone